dolichols and Arteriosclerosis

dolichols has been researched along with Arteriosclerosis* in 1 studies

Other Studies

1 other study(ies) available for dolichols and Arteriosclerosis

Article	Year
The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers. Metabolism: clinical and experimental, 1996, Volume: 45, Issue:7 We measured serum ubiquinone and dolichol concentrations in 13 men while they abused anabolic androgenic steroids (AAS) and during the following withdrawal period. Serum total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol and triglycerides were also determined. AAS administration increased serum ubiquinone by 68% (P < .001) and decreased serum dolichol by 30% (P < .002). Both nonsterol isoprenoid levels in plasma correlated with the AAS dose, ubiquinone positively (P < .001) and dolichol negatively (P < .002). When the subjects were taking steroids, the ubiquinone to LDL ratio was 42% higher than during the withdrawal period. In conclusion, our study suggests that AAS have an influence on the by-products of the mevalonate pathway. Topics: Adult; Anabolic Agents; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Dolichols; Humans; Male; Mevalonic Acid; Substance-Related Disorders; Ubiquinone	1996

Article

Year

The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers.

Metabolism: clinical and experimental, 1996, Volume: 45, Issue:7

We measured serum ubiquinone and dolichol concentrations in 13 men while they abused anabolic androgenic steroids (AAS) and during the following withdrawal period. Serum total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol and triglycerides were also determined. AAS administration increased serum ubiquinone by 68% (P < .001) and decreased serum dolichol by 30% (P < .002). Both nonsterol isoprenoid levels in plasma correlated with the AAS dose, ubiquinone positively (P < .001) and dolichol negatively (P < .002). When the subjects were taking steroids, the ubiquinone to LDL ratio was 42% higher than during the withdrawal period. In conclusion, our study suggests that AAS have an influence on the by-products of the mevalonate pathway.

Topics: Adult; Anabolic Agents; Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Dolichols; Humans; Male; Mevalonic Acid; Substance-Related Disorders; Ubiquinone

1996